stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. GKOS
    stockgist
    HomeTop MoversCompaniesConcepts
    GKOS logo

    Glaukos Corporation

    GKOS
    NYSE
    Healthcare
    Medical - Devices
    Aliso Viejo, CA, US995 employeesglaukos.com
    $112.49
    -0.15(-0.13%)

    Mkt Cap $6.5B

    $74.67
    $125.90

    52-Week Range

    At a Glance

    AI-generated

    Revenue breakdown: Glaucoma (79.7%), Corneal Health (20.3%).

    8-K
    Glaukos Corporation announced record Q4 2025 net sales of $143.1 million, up 36% year-over-year, and full year 2025 net sales of $507.4 million, up 32% year-over-year, with a one-time non-cash impairment charge of $112.9 million impacting GAAP results. The company reaffirmed 2026 net sales guidance of $600 million to $620 million.

    $6.5B

    Market Cap

    $512M

    Revenue

    -$190M

    Net Income

    Employees995
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Glaucoma79.7%($1.9B)
    Corneal Health20.3%($488M)

    Revenue by Geography

    US71.7%($1.7B)
    Non Us28.3%($682M)
    Activity

    What Changed Recently

    Financial Results
    Feb 16, 2026

    and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”

    Financial Results
    Jan 12, 2026

    and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”

    Regulation FD
    Mar 1, 2026

    and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    ARWRArrowhead Pharmaceuticals...$61.04-2.99%$8.5B39.2
    ACLXArcellx, Inc.$114.77+0.02%$6.7B-28.2
    BLCOBausch + Lomb Corporation$16.48-1.20%$5.8B-15.6
    ALKSAlkermes plc$34.84-0.58%$5.8B18.9
    BRKRBruker Corporation$36.75+1.86%$5.6B-616.1
    TFXTeleflex Incorporated$117.81-0.52%$5.2B-5.2
    MMSIMerit Medical Systems, In...$67.66-0.83%$4.0B31.5
    IRTCiRhythm Technologies, Inc...$116.72-1.27%$3.8B-85.5
    Analyst View
    Company Profile
    CIK0001192448
    ISINUS3773221029
    CUSIP377322102
    Phone949 367 9600
    Address229 Avenida Fabricante, Aliso Viejo, CA, 92672, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice